Oric Pharmaceuticals Stock Price on November 13, 2024
| ORIC Stock | USD 9.59 0.47 5.15% |
Below is the normalized historical share price chart for Oric Pharmaceuticals extending back to April 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oric Pharmaceuticals stands at 9.59, as last reported on the 23rd of November, with the highest price reaching 9.72 and the lowest price hitting 9.02 during the day.
If you're considering investing in Oric Stock, it is important to understand the factors that can impact its price. Oric Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0052, which implies the firm had a -0.0052% return per unit of risk over the last 3 months. Oric Pharmaceuticals exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oric Pharmaceuticals' Risk Adjusted Performance of 0.0357, semi deviation of 4.26, and Coefficient Of Variation of 2770.13 to confirm the risk estimate we provide.
As of November 23, 2024, Common Stock is expected to decline to 3,614. In addition to that, Total Stockholder Equity is expected to decline to about 189.3 M. As of November 23, 2024, Price Earnings Ratio is expected to decline to -4.94. In addition to that, Price Book Value Ratio is expected to decline to 2.01. Oric Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of April 2020 | 200 Day MA 10.0833 | 50 Day MA 9.62 | Beta 1.122 |
Oric |
Sharpe Ratio = -0.0052
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ORIC |
Estimated Market Risk
| 3.82 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oric Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oric Pharmaceuticals by adding Oric Pharmaceuticals to a well-diversified portfolio.
Price Book 2.3488 | Book Value 3.883 | Enterprise Value 407.5 M | Enterprise Value Ebitda 0.1311 | Shares Float 42.7 M |
Oric Pharmaceuticals Main Headline on 13th of November 2024
ORIC Pharmaceuticals Outperform Rating Reaffirmed at Wedbush by thelincolnianonline.com
Wedbush restated their outperform rating on shares of ORIC Pharmaceuticals in a research report sent to investors on Tuesday,RTT News reports. The firm currently has a 20.00 price target on the stock. A number of other research analysts also recently weighed in on ORIC. Cantor Fitzgerald reiterated an overweight rating on
Oric Pharmaceuticals Valuation on November 13, 2024
It is possible to determine the worth of Oric Pharmaceuticals on a given historical date. On November 13, 2024 Oric was worth 10.23 at the beginning of the trading date compared to the closed value of 10.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oric Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Oric Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oric Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oric Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 10.10 | 10.36 | 10.06 | 10.26 | 304,923 | |
11/13/2024 | 10.23 | 11.11 | 10.22 | 10.27 | 534,236 |
| 10.15 | 10.61 | 8.72 | 8.83 | 728,521 |
| Backtest Oric Pharmaceuticals | | | Oric Pharmaceuticals History | | | Oric Pharmaceuticals Valuation | Previous | Next |
Oric Pharmaceuticals Trading Date Momentum on November 13, 2024
| On November 14 2024 Oric Pharmaceuticals was traded for 8.83 at the closing time. The top price for the day was 10.61 and the lowest listed price was 8.72 . The trading volume for the day was 728.5 K. The trading history from November 14, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 14.02% . The trading delta at closing time against the current closing price is 10.52% . |
Oric Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Oric Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oric Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oric financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oric Pharmaceuticals Stock history
Oric Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oric is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oric Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oric Pharmaceuticals stock prices may prove useful in developing a viable investing in Oric Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 51.5 M | 36.7 M | |
| Net Loss | -80.2 M | -84.2 M |
Oric Pharmaceuticals Quarterly Net Working Capital |
|
Oric Pharmaceuticals Stock Technical Analysis
Oric Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Oric Pharmaceuticals Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Oric Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oric Pharmaceuticals November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Oric Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oric Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Oric Pharmaceuticals stock market strength indicators, traders can identify Oric Pharmaceuticals entry and exit signals to maximize returns
Oric Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oric Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Oric Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oric to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0357 | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.48) | |||
| Sortino Ratio | 0.002 | |||
| Treynor Ratio | 0.067 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |